Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

ACLOVATE

ALCLOMETASONE DIPROPIONATE

Standard Dose
0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ACLOVATE is listed in Drugs@FDA under application 018707 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ALCLOMETASONE DIPROPIONATE Form and strength CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FOUGERA PHARMS Submission history Latest submission status date: 2011-04-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview ACLOVATE is listed in Drugs@FDA under application 018707 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ALCLOMETASONE DIPROPIONATE Form and strength CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FOUGERA PHARMS Submission history Latest submission status date: 2011-04-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.